News | April 16, 2026
Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Former Wavemaker executive to lead media strategy and digital transformation agenda
Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping
Subscribe To Our Newsletter & Stay Updated
